Abstract
Background Mobile COVID-19 testing units are used worldwide to test quickly and easily individuals for COVID-19.
Aim To assess the level of fear of COVID-19 among nurses in mobile COVID-19 testing units and compare it with demographic characteristics.
Methods A cross-sectional study was conducted during November and December 2020. Study population included 57 nurses working in mobile COVID-19 testing units in Attica, Greece. We collected demographic data from the nurses, i.e. gender, age, marital status, children, living status (alone or with others), clinical experience, and chronic disease. We used the fear of COVID-19 scale to measure fear of the COVID-19 pandemic.
Results The mean score on the fear of COVID-19 scale was 14.3. Among nurses, 31.6% experienced elevated fear indicative of presence of anxiety symptoms, while the respective percentages for health anxiety and post-traumatic stress symptomatology were 22.8% and 17.5%. Fear of COVID-19 was not affected by demographic variables. However, fear was higher in females, nurses who had children and nurses who lived with others. Increased clinical experience was related with decreased fear.
Conclusions Creating a secure work environment for nurses in these units could decrease fear of COVID-19 and increase work performance.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
none
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional ethical approval from the Department of Nursing, National and Kapodistrian University of Athens (reference number: 347) was obtained prior to conducting the study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflicts of interest: none
Funding: None
Declarations of interest: None
Data Availability
Data will be available after reasonable request
